Cargando…

Reviews on biomarker studies in psychiatric and neurodegenerative disorders

Detalles Bibliográficos
Autor principal:	Guest, Paul C
Lenguaje:	eng
Publicado:	Springer 2019
Materias:	XX
Acceso en línea:	http://cds.cern.ch/record/2716812

Ejemplares similares

Reviews on biomarker studies of metabolic and metabolism-related disorders
por: Guest, Paul C
Publicado: (2019)

Reviews on biomarker studies in aging and anti-aging research
por: Guest, Paul C
Publicado: (2019)

Psychiatric disorders: neurodevelopmental disorders, neurodegenerative disorders, or both?
por: Thibaut, Florence
Publicado: (2018)

VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
por: Quinn, James P, et al.
Publicado: (2021)

Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2020)

The Treatment Of Psychiatric Disorders
por: Reid, William
Publicado: (2013)

The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders
por: Chan, Anthony W. S., et al.
Publicado: (2012)

Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
por: Hong, Heeok, et al.
Publicado: (2016)

A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
por: Lim, Keane, et al.
Publicado: (2017)

Proteostasis and Mitochondrial Role on Psychiatric and Neurodegenerative Disorders: Current Perspectives
por: Olivero, Pablo, et al.
Publicado: (2018)

Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?
por: Kocot, Joanna, et al.
Publicado: (2017)

G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
por: Wong, Thian-Sze, et al.
Publicado: (2023)

Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases
por: Bivona, Giulia, et al.
Publicado: (2022)

Healthy lifestyles and wellbeing reduce neuroinflammation and prevent neurodegenerative and psychiatric disorders
por: Kip, Elodie, et al.
Publicado: (2023)

Biomarkers in Psychiatric Disorders
por: Glannon, Walter
Publicado: (2022)

TrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders
por: Gupta, Vivek K., et al.
Publicado: (2013)

Hippocampal-Prefrontal Circuit and Disrupted Functional Connectivity in Psychiatric and Neurodegenerative Disorders
por: Li, Ming, et al.
Publicado: (2015)

Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders
por: Stefano, G. B., et al.
Publicado: (2018)

Artificial Intelligence: Deciphering the Links between Psychiatric Disorders and Neurodegenerative Disease
por: Stefano, George B., et al.
Publicado: (2023)

Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disorders
por: Maass, Fabian, et al.
Publicado: (2018)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Epigenetic Biomarkers as Diagnostic Tools for Neurodegenerative Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2021)

Physical exercise and mitochondrial function: New therapeutic interventions for psychiatric and neurodegenerative disorders
por: Sun, Lina, et al.
Publicado: (2022)

Brain transcriptomic profiling reveals common alterations across neurodegenerative and psychiatric disorders
por: Sadeghi, Iman, et al.
Publicado: (2022)

The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders
por: Tripathi, Manish Kumar, et al.
Publicado: (2020)

Editorial: Cognitive Behavior Therapy and Executive Function in Neurodegenerative Disorders, Psychiatric Disorders, and Injury Research
por: Barron, Jonathan M., et al.
Publicado: (2021)

SERUM BIOMARKERS FOR PSYCHIATRIC DISORDERS
por: Bahn, Sabine
Publicado: (2014)

Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders (RHAPSODY): a study protocol
por: Taylor, R., et al.
Publicado: (2022)

Biomarkers in neurodegenerative disorders: translating research into clinical practice
por: Menéndez-González, Manuel
Publicado: (2014)

Plasma biomarkers for neurodegenerative disorders: ready for prime time?
por: Balogun, Wasiu G., et al.
Publicado: (2023)

The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
por: Bashir, Yasir, et al.
Publicado: (2022)

Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis
por: Longinetti, Elisa, et al.
Publicado: (2017)

Shared mechanisms across the major psychiatric and neurodegenerative diseases
por: Wingo, Thomas S., et al.
Publicado: (2022)

Resting-state connectivity in neurodegenerative disorders: Is there potential for an imaging biomarker?
por: Hohenfeld, Christian, et al.
Publicado: (2018)

Unified framework for brain connectivity-based biomarkers in neurodegenerative disorders
por: Kim, Sung-Woo, et al.
Publicado: (2022)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

Biomarkers in Neurodegenerative Diseases
por: Ghosh, Arnab
Publicado: (2022)

Biomarkers for Psychiatric Disorders: Where Are We Standing?
por: Martins-de-Souza, Daniel
Publicado: (2013)

Protocol for Rhapsody: a longitudinal observational study examining the feasibility of speech phenotyping for remote assessment of neurodegenerative and psychiatric disorders
por: Hampsey, Elliot, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q8t3or9k2v80oot3j88kbbimn5